Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
NCT03547375
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
69
Enrollment
OTHER_GOV
Sponsor class
Conditions
Ovarian Cancer
Interventions
DRUG:
Apatinib
Sponsor
Anhui Provincial Hospital